Please use this identifier to cite or link to this item: http://repositorio.unifesp.br/handle/11600/37687
Title: Historical epidemiology of hepatitis C virus (HCV) in selected countries
Authors: Bruggmann, P.
Berg, T.
Ovrehus, A. L. H.
Moreno, C.
Brandao Mello, C. E.
Roudot-Thoraval, F.
Marinho, R. T.
Sherman, M.
Ryder, S. D.
Sperl, J.
Akarca, U.
Balik, I.
Bihl, F.
Bilodeau, M.
Blasco, A. J.
Buti, M.
Calinas, F.
Calleja, J. L.
Cheinquer, H.
Christensen, P. B.
Clausen, M.
Coelho, H. S. M.
Cornberg, M.
Cramp, M. E.
Dore, G. J.
Doss, W.
Duberg, A. S.
El-Sayed, M. H.
Ergor, G.
Esmat, G.
Estes, C.
Falconer, K.
Felix, J.
Ferraz, Maria Lucia Gomes [UNIFESP]
Ferreira, Paulo Roberto [UNIFESP]
Frankova, S.
Garcia-Samaniego, J.
Gerstoft, J.
Giria, J. A.
Goncales, F. L.
Gower, E.
Gschwantler, M.
Guimaraes Pessoa, M.
Hezode, C.
Hofer, H.
Husa, P.
Idilman, R.
Kaberg, M.
Kaita, K. D. E.
Kautz, A.
Kaymakoglu, S.
Krajden, M.
Krarup, H.
Laleman, W.
Lavanchy, D.
Lazaro, P.
Marotta, P.
Mauss, S.
Mendes Correa, M. C.
Muellhaupt, B.
Myers, R. P.
Negro, F.
Nemecek, V.
Ormeci, N.
Parkes, J.
Peltekian, K. M.
Ramji, A.
Razavi, H.
Reis, N.
Roberts, S. K.
Rosenberg, W. M.
Sarmento-Castro, R.
Sarrazin, C.
Semela, D.
Shiha, G. E.
Sievert, W.
Starkel, P.
Stauber, R. E.
Thompson, A. J.
Urbanek, P.
van Thiel, I.
Van Vlierberghe, H.
Vandijck, D.
Vogel, W.
Waked, I.
Wedemeyer, H.
Weis, N.
Wiegand, J.
Yosry, A.
Zekry, A.
Van Damme, P.
Aleman, S.
Hindman, S. J.
Arud Ctr Addict Med
Univ Leipzig
Odense Univ Hosp
Univ Libre Brussels
Universidade Federal do Rio de Janeiro (UFRJ)
Hop Henri Mondor
Hosp Santa Maria
Univ Toronto
Nottingham Univ Hosp NHS Trust
Biomed Res Unit
Inst Clin & Expt Med
Ege Univ
Ankara Univ
Osped Cantonale
Univ Montreal
Adv Tech Hlth Serv Res TAISS
Hosp Valle de Hebron
Hosp Santo Antonio Capuchos
Hosp Puerta Hierro
Univ Fed Rio Grande do Sul
Region Hosp Hovedstaden
Hannover Med Sch
German Liver Fdn
Univ Plymouth
Univ New S Wales
Cairo Univ
Orebro Univ Hosp
Univ Orebro
Ain Shams Univ
Dokuz Eylul Univ
Ctr Dis Anal CDA
Karolinska Inst
Exigo Consultores
Universidade Federal de São Paulo (UNIFESP)
Hosp Carlos III
Univ Copenhagen
Direccao Geral Saude
Universidade Estadual de Campinas (UNICAMP)
Wilhelminenspital Stadt Wien
Universidade de São Paulo (USP)
Med Univ Vienna
Masaryk Univ
Univ Manitoba
Hlth Sci Ctr
European Liver Patients Assoc
Istanbul Univ
Univ British Columbia
Aalborg Univ Hosp
Katholieke Univ Leuven
Univ Western Ontario
Univ Dusseldorf
Univ Zurich Hosp
Univ Calgary
Univ Hosp
Natl Inst Publ Hlth
Univ Southhampton
Dalhousie Univ
Capital Dist Hlth Author
Assembleia Republ
Alfred Hosp
Monash Univ
UCL
Ctr Hosp Porto
JW Goethe Univ Hosp
Cantonal Hosp St Gallen
Egyptian Liver Res Inst & Hosp ELRIAH
Monash Hlth
Catholic Univ Louvain
Med Univ Graz
St Vincents Hosp
Univ Melbourne
Charles Univ Prague
Cent Mil Hosp
Deutsch Leberhilfe eV
Ghent Univ Hosp
Univ Ghent
Hasselt Univ
Med Univ Innsbruck
Natl Liver Inst
Copenhagen Univ Hosp
Univ Antwerp
Karolinska Univ Hosp
Keywords: treatment
mortality
diagnosis
incidence
HCV
epidemiology
prevalence
hepatitis C
disease burden
Issue Date: 1-May-2014
Publisher: Wiley-Blackwell
Citation: Journal of Viral Hepatitis. Hoboken: Wiley-Blackwell, v. 21, p. 5-33, 2014.
Abstract: Chronic infection with hepatitis C virus (HCV) is a leading indicator for liver disease. New treatment options are becoming available, and there is a need to characterize the epidemiology and disease burden of HCV. Data for prevalence, viremia, genotype, diagnosis and treatment were obtained through literature searches and expert consensus for 16 countries. for some countries, data from centralized registries were used to estimate diagnosis and treatment rates. Data for the number of liver transplants and the proportion attributable to HCV were obtained from centralized databases. Viremic prevalence estimates varied widely between countries, ranging from 0.3% in Austria, England and Germany to 8.5% in Egypt. the largest viremic populations were in Egypt, with 6358000 cases in 2008 and Brazil with 2106000 cases in 2007. the age distribution of cases differed between countries. in most countries, prevalence rates were higher among males, reflecting higher rates of injection drug use. Diagnosis, treatment and transplant levels also differed considerably between countries. Reliable estimates characterizing HCV-infected populations are critical for addressing HCV-related morbidity and mortality. There is a need to quantify the burden of chronic HCV infection at the national level.
URI: http://repositorio.unifesp.br/handle/11600/37687
ISSN: 1352-0504
Other Identifiers: http://dx.doi.org/10.1111/jvh.12247
Appears in Collections:Em verificação - Geral

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.